Camille L. Bedrosian, Director: Rhythm Pharmaceuticals RYTM Planned sale · Filed 03/03

Trade details

Type: Planned sale notice
Stock: Rhythm Pharmaceuticals RYTM
Person: Camille L. BedrosianDirector
Planned sale date: 26/03/03
Filed: 26/03/03

$3.2M to be sold

Rhythm Pharmaceuticals trades, last 26 weeks

What else happened in Rhythm Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/01~04/02

Camille L. Bedrosian's recent trades

Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$324.9K
10,028 sh
$324.9K
Filed 09/11
Traded 09/10
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$5.8M
64,540 sh
$5.8M
Filed 03/04
Traded 03/04
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/04
Traded 03/02
Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/02
Traded 03/02
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.4K
6,580 sh
$94.4K
Filed 25/12/03
Traded 25/12/01